Safety and Pharmacodynamics of Lansoprazole in Patients with Gastroesophageal Reflux Disease Aged <1 Year

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.10, Iss.4, 2008-01, pp. : 255-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lansoprazole: In the Management of Gastroesophageal Reflux Disease in Children

By Scott L.J.

Pediatric Drugs, Vol. 5, Iss. 1, 2003-01 ,pp. : 57-61

Adis International

Access to resources Recommend Favorite

Treatment of Gastroesophageal Reflux Disease*

By Pettit Michael

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 432-435

Springer Publishing Company

Access to resources Recommend Favorite

Gastroesophageal Reflux Disease: Clinical Features*

By Pettit Michael

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 417-420

Springer Publishing Company

Access to resources Recommend Favorite

Emerging drugs for gastroesophageal reflux disease

By Boeckxstaens GE

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 481-491

Informa Healthcare

Access to resources Recommend Favorite

Acceptability of Lansoprazole Orally Disintegrating Tablets in Patients with Gastro-Oesophageal Reflux Disease: ACEPTO Study

By de Argila Carlos Martín

Clinical Drug Investigation, Vol. 27, Iss. 11, 2007-01 ,pp. : 765-770

Adis International

Access to resources Recommend Favorite